ENTA logo

Enanta Pharmaceuticals (ENTA) Current Assets

Annual Current Assets

$422.79 M
+$111.08 M+35.63%

30 September 2023

ENTA Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$286.58 M
-$64.44 M-18.36%

30 June 2024

ENTA Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTA Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--32.2%
3 y3 years+32.5%-10.2%
5 y5 years+5.2%-28.7%

ENTA Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+35.6%-36.1%+5.7%
5 y5 years-3.2%+35.6%-36.1%+5.7%
alltimeall time-3.2%+1584.5%-36.5%+1041.8%

Enanta Pharmaceuticals Current Assets History

DateAnnualQuarterly
June 2024
-
$286.58 M(-18.4%)
Mar 2024
-
$351.03 M(-10.1%)
Dec 2023
-
$390.30 M(-7.7%)
Sept 2023
$39.48 M(-38.0%)
$422.79 M(-5.7%)
June 2023
-
$448.46 M(+65.4%)
Mar 2023
-
$271.14 M(-4.4%)
Dec 2022
-
$283.70 M(-9.0%)
Sept 2022
$63.70 M(-46.8%)
$311.71 M(-0.4%)
June 2022
-
$313.04 M(-8.4%)
Mar 2022
-
$341.87 M(+4.6%)
Dec 2021
-
$326.96 M(+2.5%)
Sept 2021
$119.77 M(+143.0%)
$319.02 M(-0.7%)
June 2021
-
$321.15 M(-25.0%)
Mar 2021
-
$428.22 M(-4.0%)
Dec 2020
-
$445.94 M(+2.1%)
Sept 2020
$49.30 M(-44.0%)
$436.84 M(+5.7%)
June 2020
-
$413.38 M(+2.7%)
Mar 2020
-
$402.71 M(-8.6%)
Dec 2019
-
$440.51 M(+9.6%)
Sept 2019
$87.98 M(+160.0%)
$401.85 M(-11.0%)
June 2019
-
$451.26 M(+6.5%)
Mar 2019
-
$423.84 M(+0.1%)
Dec 2018
-
$423.31 M(+11.3%)
Sept 2018
$33.84 M
$380.39 M(+11.9%)
June 2018
-
$339.89 M(+11.2%)
DateAnnualQuarterly
Mar 2018
-
$305.68 M(+23.4%)
Dec 2017
-
$247.63 M(+4.1%)
Sept 2017
$88.82 M(+80.8%)
$237.82 M(+15.4%)
June 2017
-
$206.12 M(+8.1%)
Mar 2017
-
$190.59 M(-14.9%)
Dec 2016
-
$224.06 M(-3.5%)
Sept 2016
$49.12 M(-34.8%)
$232.16 M(-4.0%)
June 2016
-
$241.79 M(-0.4%)
Mar 2016
-
$242.66 M(+16.1%)
Dec 2015
-
$209.02 M(+22.5%)
Sept 2015
$75.37 M(+58.9%)
$170.64 M(-1.2%)
June 2015
-
$172.64 M(-2.9%)
Mar 2015
-
$177.78 M(-4.0%)
Dec 2014
-
$185.10 M(+71.4%)
Sept 2014
$47.44 M(+286.9%)
$107.97 M(-3.3%)
June 2014
-
$111.68 M(+12.4%)
Mar 2014
-
$99.35 M(+5.3%)
Dec 2013
-
$94.38 M(-9.9%)
Sept 2013
$12.26 M(+152.6%)
$104.71 M(+7.0%)
June 2013
-
$97.87 M(-12.4%)
Mar 2013
-
$111.66 M(+83.2%)
Dec 2012
-
$60.95 M(+28.8%)
Sept 2012
$4.85 M(+386.9%)
$47.31 M(-6.8%)
June 2012
-
$50.78 M(+102.3%)
Sept 2011
$997.00 K
$25.10 M

FAQ

  • What is Enanta Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly current assets year-on-year change?

What is Enanta Pharmaceuticals annual total current assets?

The current annual current assets of ENTA is $422.79 M

What is the all time high annual current assets for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual total current assets is $436.84 M

What is Enanta Pharmaceuticals quarterly total current assets?

The current quarterly current assets of ENTA is $286.58 M

What is the all time high quarterly current assets for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly total current assets is $451.26 M

What is Enanta Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, ENTA quarterly total current assets has changed by -$136.21 M (-32.22%)